Track FHTX and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
FHTX - Foghorn Therapeutics Inc (FHTX) has a free cash flow of -$86.15M, up 15.0% over the past year and down 14.3% per year over the past five years.
FCF TTM
-$86.15M
FCF Margin
-278.72%
FCF Yield
-26.53%
5Y CAGR
-14.32%
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$86.15M | +14.97% |
| 2024 | -$101.31M | +15.10% |
| 2023 | -$119.33M | -162.02% |
| 2022 | $192.40M | +459.21% |
| 2021 | -$53.56M | -12.84% |
| 2020 | -$47.47M | -0.35% |
| 2019 | -$47.30M | - |
| Quarter | Free Cash Flow | Change |
|---|---|---|
| Q4 2025 | -$22.27M | -18.09% |
| Q3 2025 | -$18.86M | +10.28% |
| Q2 2025 | -$21.02M | +12.39% |
| Q1 2025 | -$24.00M | +4.01% |
| Q4 2024 | -$25.00M | -17.28% |
| Q3 2024 | -$21.31M | +16.59% |
| Q2 2024 | -$25.55M | +13.22% |
| Q1 2024 | -$29.45M | -6.77% |
| Q4 2023 | -$27.58M | -1.05% |
| Q3 2023 | -$27.29M | +16.40% |
| Q2 2023 | -$32.64M | -2.60% |
| Q1 2023 | -$31.82M | -8.99% |
| Q4 2022 | -$29.19M | -43.69% |
| Q3 2022 | -$20.32M | +30.84% |
| Q2 2022 | -$29.38M | -110.83% |
| Q1 2022 | $271.29M | +2198.65% |
| Q4 2021 | $11.80M | +156.93% |
| Q3 2021 | -$20.73M | -5.28% |
| Q2 2021 | -$19.69M | +21.05% |
| Q1 2021 | -$24.94M | -37.46% |
| Q4 2020 | -$18.14M | -572.25% |
| Q3 2020 | -$2.70M | +81.82% |
| Q2 2020 | -$14.84M | -25.97% |
| Q1 2020 | -$11.78M | +11.49% |
| Q4 2019 | -$13.31M | -7.91% |
| Q3 2019 | -$12.34M | -13.93% |
| Q2 2019 | -$10.83M | +0.00% |
| Q1 2019 | -$10.83M | +8.44% |
| Q4 2018 | -$11.83M | -95.56% |
| Q2 2018 | -$6.05M | +0.00% |
| Q1 2018 | -$6.05M | +0.00% |
| Q4 2017 | -$6.05M | - |
Free cash flow (FCF) is the cash left after a company covers its operating expenses and capital expenditures. It is the money available to repay debt, buy back shares, pay dividends, or reinvest — making it one of the clearest measures of financial strength.